Skip to content

C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02083159
Enrollment
500
Registered
2014-03-11
Start date
2012-03-31
Completion date
Unknown
Last updated
2016-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NAFLD

Brief summary

Non-alcoholic fatty liver disease (NAFLD) is characterized by an accumulation of fat in the liver, which is one of the most common forms of chronic liver disease in developed countries. In western countries, the prevalence of NAFLD in the general population is estimated to be 20-30%; in obese populations, this increases to 57.5-74%. But, it hasn't been clearly elucidated yet regarding the underlying disease pathophysiology and treatmet strategy. Recently, members of the C1q/tumor necrosis factor-related protein (CTRP) family have been reported to share structural homology with adiponectin. To date, 15 CTRP family members have been found that might play major roles in glucose metabolism and inflammation. The investigators tried to clarify the relationship between CTRP family and NAFLD in Korean men and women.

Interventions

None listed

Sponsors

Korea University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* 20\<age\<80 * apparently healthy subjects

Exclusion criteria

* a history of CVD * diabetes * stage 2 hypertension * malignancy * severe renal or hepatic disease

Design outcomes

Primary

MeasureTime frame
serum concentration of CTRP-1, 3, or 9 in the subjects with/without NAFLDat enrollment

Secondary

MeasureTime frame
The relationships of serum CTRPs/adiponectin levels with cardiometabolic risk profilesat enrollment

Countries

South Korea

Contacts

Primary ContactHo Cheol Hong, M.D.
naeyo21@naver.com822-2626-3044
Backup ContactKyung Mook Choi, M.D.
medica7@gmail.com822-2626-3043

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026